GRI Bio reports Q1 results

1 month ago 3

Earnings News

GRI Bio press release (NASDAQ:GRI): Q1 net loss was $3 million.
As of March 31, 2025, the company had cash and cash equivalents of approximately $3.3 million. After the end of the quarter, the company closed a public offering for aggregate gross proceeds of $5.0 million. Based

Recommended For You

More Trending News

Read Entire Article